BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25169547)

  • 1. The CCND1 G870A gene polymorphism and leukemia or non-Hodgkin lymphoma risk: a meta-analysis.
    Qin LY; Zhao LG; Chen X; Yang Z; Mo WN
    Asian Pac J Cancer Prev; 2014; 15(16):6923-8. PubMed ID: 25169547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CCND1 G870A gene polymorphism and brain tumor risk: a meta-analysis.
    Qin LY; Zhao LG; Chen X; Li P; Yang Z; Mo WN
    Asian Pac J Cancer Prev; 2014; 15(8):3607-12. PubMed ID: 24870765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
    Xie M; Zhao F; Zou X; Jin S; Xiong S
    Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
    Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
    Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
    Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
    PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between
    Thakur N; Kumari S; Mehrotra R
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between the G870A polymorphism of Cyclin D1 gene and glioma risk.
    Zong H; Cao L; Ma C; Zhao J; Ming X; Shang M; Xu H
    Tumour Biol; 2014 Aug; 35(8):8095-101. PubMed ID: 24840634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
    Hu YY; Zheng R; Guo C; Niu YM
    Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.
    Wu Y; Fu H; Zhang H; Huang H; Chen M; Zhang L; Yang H; Qin D
    Tumour Biol; 2014 Jul; 35(7):6913-8. PubMed ID: 24737585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
    Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
    Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
    Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.
    Akhter N; Alzahrani FA; Dar SA; Wahid M; Sattar RSA; Hussain S; Haque S; Ansari SA; Jawed A; Mandal RK; Almalki S; Alharbi RA; Husain SA
    J Cell Biochem; 2019 Oct; 120(10):16452-16466. PubMed ID: 31243808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis.
    Zhao Y; He HR; Wang MY; Ren XD; Zhang L; Dong YL; Lu J
    Genet Mol Res; 2015 May; 14(2):5171-80. PubMed ID: 26125710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
    Chen B; Cao L; Yang P; Zhou Y; Wu XT
    Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCND1 G870A polymorphism and colorectal cancer risk: An updated meta-analysis.
    Xu XM; Ni XB; Yang GL; Luo ZG; Niu YM; Shen M
    Mol Clin Oncol; 2016 Jun; 4(6):1078-1084. PubMed ID: 27284448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis.
    Meng Y; Zhang C; Zhou X
    Onco Targets Ther; 2016; 9():367-76. PubMed ID: 26855585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta-analysis.
    Wen L; Hu YY; Yang GL; Liu DX
    Biomed Rep; 2014 Jul; 2(4):549-554. PubMed ID: 24944806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis.
    Wang L; Wang Z; Gao X; Li X; Sun X; Liu C
    Tumour Biol; 2014 Feb; 35(2):1149-55. PubMed ID: 24186074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis.
    Tang C; Wang Z; Yu J; Wu Y; Zhu Z; Chen N
    Med Oncol; 2011 Dec; 28(4):1319-24. PubMed ID: 20443083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
    Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
    Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.